In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
On May 18, 2022, AMCP hosted Legislative Days where AMCP members and the AMCP Policy and Government Relations team met virtually with U.S. Senators and Representatives to advocate for AMCP's top policy priorities. Learn more about the role Legislative Days plays in achieving our mission to improve patient health by ensuring access to high-quality, cost-effective medications and other therapies.
By Jennifer Mathieu, Vice President, Policy and Government Relations • 6/15/22
In this guest blog post, Tenicia Talley, PharmD, MSCR, discussespharmacoequity and how this applies to AMCP's efforts in addressing racial health disparities.
From thought-provoking keynote sessions to networking opportunities, AMCP CEO, Susan Cantrell, MHL, RPh, CAE, highlights what AMCP 2022 attendees can look forward to at the annual meeting.